Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianchen Zhao

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Vaccines|May 27, 2023
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, JapanYuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Vaccines|April 23, 2022
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community SurveyMakoto Yoshida, Yurie Kobashi, Takeshi Kawamura, et al.
Case Reports in Nephrology|April 15, 2026
Indirect Disaster-Related Deaths Among Hemodialysis Patients Following the Fukushima Daiichi Nuclear Power Plant AccidentRyoma Yoshida, Toyoaki Sawano, Yuna Uchi, et al.
Vaccines|February 28, 2023
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational StudyMoe Kawashima, Hiroaki Saito, Takamitsu Nishiuchi, et al.
Scientific Reports|February 5, 2024
Categorization of disaster-related deaths in Minamisoma city after the Fukushima nuclear disaster using clustering analysisHiroki Yoshimura, Toyoaki Sawano, Michio Murakami, et al.
Scientific Reports|November 7, 2022
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community SurveyYurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, et al.
PLOS Digital Health|May 3, 2024
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general populationNaotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Vaccines|May 27, 2023
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, JapanYuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Vaccines|April 23, 2022
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community SurveyMakoto Yoshida, Yurie Kobashi, Takeshi Kawamura, et al.
Case Reports in Nephrology|April 15, 2026
Indirect Disaster-Related Deaths Among Hemodialysis Patients Following the Fukushima Daiichi Nuclear Power Plant AccidentRyoma Yoshida, Toyoaki Sawano, Yuna Uchi, et al.
Vaccines|February 28, 2023
Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational StudyMoe Kawashima, Hiroaki Saito, Takamitsu Nishiuchi, et al.
Scientific Reports|February 5, 2024
Categorization of disaster-related deaths in Minamisoma city after the Fukushima nuclear disaster using clustering analysisHiroki Yoshimura, Toyoaki Sawano, Michio Murakami, et al.
Scientific Reports|November 7, 2022
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community SurveyYurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, et al.
PLOS Digital Health|May 3, 2024
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general populationNaotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, et al.
Science Translational Medicine|September 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infectionHyeongki Park, Naotoshi Nakamura, Sho Miyamoto, et al.
Pageof 7